In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods

Medical Mycology

Volumn 87, Issue 8, 2012, Pages 795-801

  Cafarchia, Claudia ^a   Figueredo, Luciana A ^a   Iatta, Roberta ^b   Colao, Valeriana ^a   Montagna, Maria T ^b   Otranto, Domenico ^a  

^a Facolta di Medicina Veterinaria   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Antifungal susceptibility; CLSI reference broth microdilution method; E test; Genotype; Malassezia pachydermatis

Indexed keywords

CHS 2 PROTEIN; FLUCONAZOLE; FUNGAL PROTEIN; ITRACONAZOLE; ITS 1 PROTEIN; KETOCONAZOLE; LSU PROTEIN; POSACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

AMPLICON; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CONTROLLED STUDY; DOG; EPSILOMETER TEST; FUNGAL STRAIN; FUNGUS ISOLATION; GENOTYPE; IN VITRO STUDY; INTERMETHOD COMPARISON; MALASSEZIA DERMATITIS; MALASSEZIA PACHYDERMATIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SKIN DEFECT;

ANIMALS; ANTIFUNGAL AGENTS; AZOLES; DOGS; MALASSEZIA; MICROBIAL SENSITIVITY TESTS;

ANIMALIA; CANIS FAMILIARIS; MALASSEZIA; MALASSEZIA PACHYDERMATIS;

EID: 84867562723     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.674219     Document Type: Article

References (38)

1. Batra R, Boekhout T, Gu é ho E, et al Malassezia Baillon, emerging clinical yeasts. FEMS Yeast Res 2005; 5 : 1101-1113. (Pubitemid 41607731)
2. Cafarchia C, Otranto D. Association between phospholipase production by Malassezia pachydermatis and skin lesions. J Clin Microbiol 2004; 4 : 4868-4869. (Pubitemid 39362428)
3. Cafarchia C, Dell' A quila ME, Capelli G, Minoia P, Otranto D. Role of beta-endorphin on phospholipase production in Malassezia pachydermatis in dogs: new insights into the pathogenesis of this yeast. Med Mycol 2007; 45 : 11-15. (Pubitemid 46992913)
4. Cafarchia C, Dell 'Aquila ME, Traversa D, et al Expression of the micro-opioid receptor on Malassezia pachydermatis and its effect in modulating phospholipase production. Med Mycol 2010; 48 : 73-78.
5. Miceli MH, D í az JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11 : 142-151.
6. Cafarchia C, Gallo S, Capelli G, Otranto D. Occurrence and population size of Malassezia spp. in the external ear canal of dogs and cats both healthy and with otitis. Mycopathologia 2005; 160 : 143-149. (Pubitemid 41361235)
7. Cafarchia C, Gallo S, Romito D, et al Frequency, body distribution, and population size of Malassezia species in healthy dogs and in dogs with localized cutaneous lesions. J Vet Diagn Invest 2005; 17 : 316-322. (Pubitemid 41003476)
8. Bond R. Superfi cial veterinary mycoses. Clin Dermatol 2010; 28 : 226-236.
9. Morris DO. Malassezia pachydermatis carriage in dog owners. Emerg Infect Dis 2005; 11 : 83-88. (Pubitemid 40093357)
10. Chang HJ, Miller HL, Watkins N, e t al An epidemic of M alassezia pachydermatis in an intensive care nursery associated with colonization of health care workers 'pet dogs. N Engl J Med 1998; 338 : 706-711. (Pubitemid 28115088)
11. Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001; 90 : 323-327. (Pubitemid 32299554)
12. Negre A, Bensignor E, Guillot J. Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. Vet Dermatol 2009; 20 : 1-12.
13. Nijima M, Kano R, Nagata M, Hasegawa A, Kamata H. An azoleresistant isolate of Malassezia pachydermatis Vet Microbiol 2011; 149 : 288-290.
14. Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions. Vet Microbiol 2012; 155: 395-398.
15. Cafarchia C, Latrofa MS, Testini G, et al Molecular characterization of Malassezia isolates from dogs using three distinct genetic markers in nuclear DNA. Mol Cell Probes 2007; 21 : 229-238. (Pubitemid 46420636)
16. Cafarchia C, Gasser RB, Latrofa MS, et al Genetic variants of Malassezia pachydermatis from canine skin: body distribution and phospholipase activity. FEMS Yeast Res 2008; 8 : 451-459. (Pubitemid 351579658)
17. Clinical Laboratory and Standards Institute. R eference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved standard, 3rd edn, document M27-A3. Wayne, PA: Clinical Laboratory and Standards Institute, 2008.
18. Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modifi ed NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 2004; 242 : 3589-3593. (Pubitemid 39045685)
19. Cant ó n E, Espinel-Ingroff A, Pemán J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther 2009; 7 : 107-119.
20. Lorenzini R, Mercantini R, De Bernardis F. In vitro sensitivity of Malassezia spp. to various antimycotics. Drugs Exp Clin Res 1985; 11 : 393- 395. (Pubitemid 15246074)
21. Bernardo FM, Martins HM, Martins ML. A survey of mycotic otitis externa of dog in Lisbon. Rev Iberoam Micol 1998; 15 : 163-165. (Pubitemid 128532752)
22. Rougier S, Borell D, Pheulpin S e t al A comparative study of two antimicrobial/anti-infl ammatory formulations in the treatment of canine otitis externa. Vet Dermatol 2005; 16 : 299-307. (Pubitemid 41626152)
23. Nascente PS, Nobre MO, Schuch LF, et al Evaluation of Malassezia pachydermatis antifungal susceptibility using two different methods. Braz J Microbiol 2003; 34 : 359-362. (Pubitemid 40747490)
24. Nascente PS, Mano Meinerz AR, Os ó rio de Faria R, e t al CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole. Braz J Microbiol 2009; 40 : 222-226.
25. Guillot J, Gu é ho E, Lesourd M, et al Identifi cation of Malassezia species. A practical approach. J Mycol Med 1996; 6 : 103-111.
26. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTALX windows interface: fl exible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25 : 4876-4882. (Pubitemid 28022245)
27. Morace G, Borghi E, Iatta R, et al. Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients. BMC Infect Dis 2011; 11 : 130.
28. Cuenca-Estrella M, Rodriguez D, Almirante B, et al In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother 2005; 55 : 194-199. (Pubitemid 40331145)
29. Rex JH, Pfaller MA, Galgiani JN, et al Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fl uconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 1997; 24 : 235-247. (Pubitemid 127774263)
30. Eichenberg M, Appelt CE, Berg V, et al Susceptibility of Malassezia pachydermatis to azole antifungal agent evaluate by a new broth microdilution method. Acta Sci Vet 2003; 31 : 75-80.
31. Jesus FP, Lautert C, Zanette RA, e t al In vitro susceptibility of fl uconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Vet Microbiol 2011; 152 : 161-164.
32. Iatta R, Caggiano G, Cuna T, Montagna MT. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia. J Chemother 2011; 23 : 92-96.
33. Jorgensen JH. Selection criteria for an antimicrobial susceptibility testing system. J Clin Microbiol 1993; 31 : 2841-2844. (Pubitemid 23318365)
34. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346 : 1085-1087.
35. Sugita T, Tajima M, Ito T, et al Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005; 43 : 2824-2829. (Pubitemid 40827960)
36. Xu J, Saunders CW, Hu P, et al Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens Proc Natl Acad Sci USA 2007; 104 : 18730-18735. (Pubitemid 350210765)
37. Hitchcock CA, Barrett-Bee KJ, Russell NJ. The lipid composition and permeability to the triazole antifungal antibiotic ICI 153066 of serumgrown mycelial cultures of Candida albicans J Gen Microbiol 1989; 135 : 1949-1955. (Pubitemid 19197058)
38. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20 : 133- 163. (Pubitemid 46167771)